Peptide Library

In clinical trials

Digestive & weight

Larazotide acetate

Evidence

Clinical trials

Class

Tight-junction regulator peptide

/

Larazotide acetate

KEY TAKEAWAY

Larazotide acetate is an eight-amino-acid peptide designed to keep the gaps between cells of the intestinal lining closed. It was developed for celiac disease. Larazotide is not FDA-approved. A phase 3 trial in celiac disease was stopped in 2022 after an interim review suggested it was unlikely to meet its goal.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Tight-junction regulator peptide

Being studied for

Studied as an add-on to a gluten-free diet in celiac disease

Key fact

Larazotide is not FDA-approved. A phase 3 trial in celiac disease was stopped in 2022 after an interim review suggested it was unlikely to meet its goal.

Route

Oral capsule taken before meals in trials

Evidence strength

Clinical trials

What it is

What it is

Larazotide acetate is an eight-amino-acid peptide designed to keep the gaps between cells of the intestinal lining closed. It was developed for celiac disease.

How it works

How it works

It is thought to block zonulin signaling, which loosens those cell-to-cell seals, so that fewer gluten fragments cross the gut wall.

Regulatory status

Regulatory status

Larazotide is not FDA-approved. A phase 3 trial in celiac disease was stopped in 2022 after an interim review suggested it was unlikely to meet its goal.

What it is used for

What it is used for

Studied as an add-on to a gluten-free diet in celiac disease.

Side effects and risks

Side effects and risks

Reported side effects in trials were similar to placebo, but a clear benefit was not shown.

Citations

Citations

Larazotide acetate: see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo